Key stats
About ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF
Expense ratio
0.35%
Home page
Inception date
Mar 6, 2018
ISIN
IE00BDZVHG35
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region